Open Access

Sevoflurane alleviates oxygen‑glucose deprivation/reoxygenation‑induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway

  • Authors:
    • Qiong Yu
    • Haofei Dai
    • Yinan Jiang
    • Yifeng Zha
    • Jie Zhang
  • View Affiliations

  • Published online on: February 19, 2021     https://doi.org/10.3892/etm.2021.9807
  • Article Number: 376
  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Sevoflurane (Sev), a volatile anesthetic, has been reported to exhibit beneficial effects on different ischemia/reperfusion (I/R)‑injured organs. However, the neuroprotective effect of Sev on cerebral I/R injury is poorly understood. In the present study, the effects of Sev on HT22 cells exposed to oxygen‑glucose deprivation/reperfusion (OGD/R) injury are investigated. The present study demonstrated that OGD/R suppressed the cell viability and increased lactate dehydrogenase (LDH) release from the cells, and these effects were attenuated by Sev treatment. The results also demonstrated that Sev alleviated OGD/R‑induced cell apoptosis via flow cytometry and caspase‑3 activity determination. Biochemical analysis results revealed that Sev significantly protected against OGD/R‑induced oxidative stress by reducing ROS generation and improving antioxidant defense markers. Western blot analysis demonstrated that Sev reactivated the PI3K/AKT/glycogen synthase kinase‑3β (GSK3β) signaling pathway, which was inhibited by OGD/R. In addition, wortmannin, a selective PI3K inhibitor was used to investigate the underlying pathways. Notably, the neuroprotective effect of Sev on apoptosis and reactive oxygen species production was found to be suppressed by wortmannin. Collectively, these results demonstrated that Sev may protect neuronal cells against OGD/R‑induced injury through the activation of the PI3K/AKT/GSK3β signaling pathway. The findings from the present study provide a novel insight into understanding the neuroprotective effect of Sev on cerebral I/R injury.
View Figures
View References

Related Articles

Journal Cover

April-2021
Volume 21 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu Q, Dai H, Jiang Y, Zha Y and Zhang J: Sevoflurane alleviates oxygen‑glucose deprivation/reoxygenation‑induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway. Exp Ther Med 21: 376, 2021
APA
Yu, Q., Dai, H., Jiang, Y., Zha, Y., & Zhang, J. (2021). Sevoflurane alleviates oxygen‑glucose deprivation/reoxygenation‑induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway. Experimental and Therapeutic Medicine, 21, 376. https://doi.org/10.3892/etm.2021.9807
MLA
Yu, Q., Dai, H., Jiang, Y., Zha, Y., Zhang, J."Sevoflurane alleviates oxygen‑glucose deprivation/reoxygenation‑induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway". Experimental and Therapeutic Medicine 21.4 (2021): 376.
Chicago
Yu, Q., Dai, H., Jiang, Y., Zha, Y., Zhang, J."Sevoflurane alleviates oxygen‑glucose deprivation/reoxygenation‑induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway". Experimental and Therapeutic Medicine 21, no. 4 (2021): 376. https://doi.org/10.3892/etm.2021.9807